Bank Of The West Abb Vie Inc. Transaction History

Bank Of The West

$851 Million
Q4 2022

A detailed history of Bank Of The West transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Of The West holds 55,067 shares of ABBV stock, worth $11 Million. This represents 1.05% of its overall portfolio holdings.

Number of Shares

55,067

Previous 54,162 1.67%

Holding current value

$11 Million

Previous $7.27 Million 22.49%

% of portfolio

1.05%

Previous 0.95%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 31, 2023	BUY	$138.31 - $165.87 $125,170 - $150,112	905 Added 1.67%	55,067 $8.9 Million
Q3 2022 Oct 31, 2022	SELL	$134.21 - $153.93 $152,596 - $175,018	-1,137 Reduced 2.06%	54,162 $7.27 Million
Q2 2022 Aug 02, 2022	SELL	$137.62 - $174.96 $147,528 - $187,557	-1,072 Reduced 1.9%	55,299 $8.47 Million
Q1 2022 Apr 22, 2022	SELL	$131.98 - $163.75 $75,360 - $93,501	-571 Reduced 1.0%	56,371 $9.14 Million
Q4 2021 Jan 28, 2022	BUY	$107.43 - $135.93 $279,747 - $353,961	2,604 Added 4.79%	56,942 $7.71 Million
Q3 2021 Nov 09, 2021	BUY	$106.4 - $120.78 $83,417 - $94,691	784 Added 1.46%	54,338 $5.86 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $223,886 - $249,422	-2,128 Reduced 3.82%	53,554 $6.03 Million
Q1 2021 May 10, 2021	BUY	$102.3 - $112.62 $171,250 - $188,525	1,674 Added 3.1%	55,682 $6.03 Million
Q4 2020 Feb 02, 2021	BUY	$80.49 - $108.67 $339,345 - $458,152	4,216 Added 8.47%	54,008 $5.79 Million
Q3 2020 Nov 05, 2020	SELL	$85.91 - $100.83 $68,728 - $80,664	-800 Reduced 1.58%	49,792 $4.36 Million
Q2 2020 Aug 10, 2020	BUY	$73.37 - $98.18 $57,228 - $76,580	780 Added 1.57%	50,592 $4.97 Million
Q1 2020 May 08, 2020	SELL	$64.5 - $97.79 $483,750 - $733,425	-7,500 Reduced 13.09%	49,812 $3.8 Million
Q4 2019 Feb 10, 2020	SELL	$72.13 - $90.25 $114,542 - $143,317	-1,588 Reduced 2.7%	57,312 $5.07 Million
Q3 2019 Oct 28, 2019	BUY	$62.98 - $75.72 $341,729 - $410,856	5,426 Added 10.15%	58,900 $4.46 Million
Q2 2019 Jul 18, 2019	SELL	$65.7 - $83.98 $225,285 - $287,967	-3,429 Reduced 6.03%	53,474 $3.89 Million
Q1 2019 Apr 09, 2019	SELL	$77.14 - $90.79 $4,165 - $4,902	-54 Reduced 0.09%	56,903 $4.59 Million
Q4 2018 Feb 07, 2019	BUY	$77.85 - $96.01 $137,716 - $169,841	1,769 Added 3.21%	56,957 $5.25 Million
Q3 2018 Nov 02, 2018	SELL	$88.91 - $98.84 $48,100 - $53,472	-541 Reduced 0.97%	55,188 $5.22 Million
Q2 2018 Jul 25, 2018	SELL	$89.78 - $106.23 $137,183 - $162,319	-1,528 Reduced 2.67%	55,729 $5.16 Million
Q1 2018 May 08, 2018	SELL	$92.01 - $123.21 $129,090 - $172,863	-1,403 Reduced 2.39%	57,257 $5.42 Million
Q4 2017 Feb 05, 2018	SELL	$89.56 - $98.21 $388,869 - $426,427	-4,342 Reduced 6.89%	58,660 $5.67 Million
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $4.4 Million - $5.62 Million	63,002	63,002 $5.6 Million

Others Institutions Holding ABBV

# of Institutions

3,795

Shares Held

1.28B

Call Options Held

13M

Put Options Held

9.82M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $353B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of The West, based on Form 13F filings with the SEC.

News

Stay updated on Bank Of The West with notifications on news.

Account